Prescription digital therapeutics: A new frontier for pharmacists and the future of treatment
Journal of the American Pharmacists Association · 2023-07 · 63 (4) · 1030-1034
DOI: 10.1016/j.japh.2023.03.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2023-07. Verfasst von Gigi Shafai und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Pharmacists, Prescriptions. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Pearl Therapeutics.
Abstract (Originalsprache)
Within digital health, digital therapeutics (DTx) are increasingly used to provide clinical treatment. DTx are evidence-based, U.S. Food and Drug Administration-authorized software to treat or manage medical conditions and are available either via prescription or as nonprescription products. DTx that require clinician initiation and oversight are called prescription DTx (PDTs). DTx and PDTs have unique mechanisms of action and are expanding treatment options beyond traditional pharmacotherapy. They may be implemented on their own or used in combination with a drug and in some cases may be the only treatment option for a particular disease state. This article explains how DTx and PDTs function and how these technologies can be incorporated by pharmacists as they attend to their patients' care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- Pearl Therapeutics
Zitieren
APA
Shafai, G., & Aungst, T. D. (2023). Prescription digital therapeutics: A new frontier for pharmacists and the future of treatment. Journal of the American Pharmacists Association, 63(4), 1030-1034. https://doi.org/10.1016/j.japh.2023.03.012
Vancouver
Shafai G, Aungst TD. Prescription digital therapeutics: A new frontier for pharmacists and the future of treatment. Journal of the American Pharmacists Association. 2023;63(4):1030-1034. doi:10.1016/j.japh.2023.03.012
BibTeX
@article{Shafai2023,
author = {Shafai, Gigi and Aungst, Timothy D},
title = {Prescription digital therapeutics: A new frontier for pharmacists and the future of treatment},
journal = {Journal of the American Pharmacists Association},
year = {2023},
volume = {63},
number = {4},
pages = {1030--1034},
doi = {10.1016/j.japh.2023.03.012}
}
EUVIMED